Egle Therapeutics
Paris
About Egle Therapeutics
Egle Therapeutics is an emerging biotechnology company focused on developing First-In-Class immunotherapies targeting immune suppressor regulatory T-cells (Tregs) for oncology and autoimmune diseases. The company was founded in 2020 and is based in Paris, France.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $66.2M
- Funding stage: Early Stage Venture
- Last round: Grant (Mar 2026)
- Website: egle-tx.com
- Phone: +33-186640857
Industries & Categories
Biotechnology, Health Care, Oncology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/egle-therapeutics-20703 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.